Aug 12, 2021 / 01:00PM GMT
Anna Niedl - Medigene AG - VP, IR & Corporate Communications
Good afternoon and good morning to the US. My name is Anna Niedl. I'm responsible for Investor Relations at Medigene. I would like to welcome everybody also from my side to today's conference call in which we will describe Medigene's financial and operational results in the first half year of 2021.
Today's presentation is available for download on our website and this call will be recorded and will be accessible later on our website as well.
With us today on this conference call are Dolores Schendel, our Chief Executive and Chief Scientific Officer at Medigene; and Axel Malkomes, our Chief Financial and Chief Business Officer.
I would draw your attention to slide 2 and would like to remind you that as usual, during this conference call, we will present and discuss certain forward-looking statements. Please have a look at slide 2. And with that, I would like now to hand over to Axel Malkomes.
Axel Malkomes - Medigene AG - CFO & Chief Business Development Officer
Q2 2021 Medigene AG Earnings Call Transcript
Feb 14, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers